Penumbra (PEN) Income from Non-Controlling Interests (2018 - 2021)
Penumbra (PEN) reported Income from Non-Controlling Interests of -$819000.0 for Q3 2021, up 22.81% year-over-year from -$666891.0 in Q3 2020, and up 12.12% quarter-over-quarter from -$932000.0 in Q2 2021.
Penumbra (PEN) Income from Non-Controlling Interests (2018 - 2021) Analysis & Trends
Penumbra (PEN) has 4 years of Income from Non-Controlling Interests data on file, last reported at -$819000.0 in Q3 2021.
- Income from Non-Controlling Interests for Q3 2021 came in at -$819000.0, up 22.81% year-over-year; the trailing twelve-month figure through Jun 2022 was -$819000.0 (up 79.1% YoY), and the FY2021 annual result was -$2.7 million, up 25.15% from the prior year.
- Income from Non-Controlling Interests improved to -$819000.0 in Q3 2021 per PEN's latest filing, from -$932000.0 in the prior quarter.
- Over five years, Income from Non-Controlling Interests peaked at -$195000.0 in Q4 2018 and troughed at -$3.5 million in Q3 2018.
- A 4-year average of -$873923.1 and a median of -$819000.0 in 2021 frame the typical range for Income from Non-Controlling Interests.
- The sharpest annual moves came in 2019 and 2020: Income from Non-Controlling Interests jumped 86.18% in 2019, then slumped 177.58% in 2020.
- A 4-year view of Income from Non-Controlling Interests shows it stood at -$195000.0 in 2018, then plunged by 98.97% to -$388000.0 in 2019, then tumbled by 161.86% to -$1.0 million in 2020, then increased by 19.39% to -$819000.0 in 2021.
- Business Quant data shows PEN's Income from Non-Controlling Interests at -$819000.0 in Q3 2021, -$932000.0 in Q2 2021, and -$910000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | - |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 6.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 22.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -5.85 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 100,000.00 |
| 10 | Penumbra | 12.51 Bn | 11.90 Bn | 253.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -819,000.00 |
| Jun 30, 2021 | -932,000.00 |
| Mar 31, 2021 | -910,000.00 |
| Dec 31, 2020 | -1.02 Mn |
| Sep 30, 2020 | -1.06 Mn |
| Jun 30, 2020 | -941,000.00 |
| Mar 31, 2020 | -537,000.00 |
| Dec 31, 2019 | -388,000.00 |
| Sep 30, 2019 | -483,000.00 |
| Jun 30, 2019 | -339,000.00 |
| Mar 31, 2019 | -244,000.00 |
| Dec 31, 2018 | -195,000.00 |
| Sep 30, 2018 | -3.50 Mn |